ASU Biodesign Institute

What ASU Biodesign Institute does

The ASU Biodesign Institute is a university research institute within Arizona State University, founded in 2004 as the first U.S. institute devoted entirely to interdisciplinary, nature-inspired science addressing health, sustainability, and security challenges. It operates 16 research centers staffed by hundreds of scientists — including Nobel laureate Lee Hartwell and Stockholm Water Prize laureate Bruce Rittmann — supported by graduate and undergraduate students. Core technical capabilities span structural DNA nanotechnology, the first-of-its-kind Compact X-ray Free Electron Laser (CXFEL, backed by a $90.8M NSF award), immunosignature diagnostics, DNA nanobot therapeutics, plant-based vaccine production, and AI-driven disease surveillance. The portfolio includes 382 patents, 1,115 inventions, 300+ active research projects, and 57 spinout companies commercialized through Skysong Innovations.

The institute's revenue model is grant- and donation-funded rather than commercial: more than half of research dollars come from the National Institutes of Health, supplemented by NSF, philanthropy (notably the Virginia G. Piper Charitable Trust), and corporate partners (Open Philanthropy Project, OncoMyx Therapeutics). In FY2020, scientists submitted $283M in proposals and recorded $39.4M in external research expenditures, against cumulative external funding of $1 billion since formation. The ASU Clinical Testing Laboratory — established in 2020 — added a clinical-services revenue stream (800,000+ COVID-19 tests processed). Strategic partners include Mayo Clinic, Banner Health, TGen, Mt. Sinai, the U.S. Army Medical Research Institute of Infectious Diseases, and Cornell. The institute's GTM is community-led, with Skysong Innovations acting as the technology-transfer and spinout-creation engine. Geographic scope is Arizona-anchored with global scientific collaboration.

Name

ASU Biodesign Institute

Legal name

Biodesign Institute at Arizona State University

Website

https://biodesign.asu.edu

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The ASU Biodesign Institute is a nonprofit research institute within Arizona State University that conducts interdisciplinary, nature-inspired science across 16 centers, developing diagnostics, vaccines, and environmental technologies funded by federal grants, philanthropy, and corporate partnerships, and commercialized via 57 spinout companies.

Ownership category

akta.pro rank

Product category

Biomedical Research Institute

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)

Keywords

• Biomedical research institute
• Interdisciplinary life sciences
• Environmental biotechnology research
• Clinical diagnostics services
• Translational research programs

Headquarters

HQ city

Tempe

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Others

Revenue model

1. Government Research Grants: Majority of research funding comes from government agencies, with more than half from the National Institutes of Health. In fiscal year 2020, scientists submitted $283 million in proposals with $39.4 million in external research expenditures.
2. Corporate Partnerships: Funding and collaboration from corporations such as Open Philanthropy Project and OncoMyx Therapeutics for research programs
3. Philanthropic Donations: Individual gifts and donations from donors that support research, education, training, attracting top scientists, and student opportunities. Virginia G. Piper Charitable Trust mentioned as major donor.
4. Technology Commercialization: Spinout companies launched from research (57 companies as of January 2026) and technology licensing through Skysong Innovations

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

The Biodesign Institute performs interdisciplinary, nature-inspired scientific research addressing global challenges in health (cancer, infectious diseases, neurodegenerative disease), sustainability (water, bioremediation, bioplastics), and security (biodefense, biocomputing). It delivers research and clinical services across 16 specialized centers, including a state-certified Clinical Testing Laboratory for COVID-19 saliva PCR diagnostics and the first-of-its-kind Compact X-ray Free Electron Laser (CXFEL) facility. The institute operates within Arizona State University and translates discoveries into commercial products through technology licensing and 57 spinout companies.

Product overview

The ASU Biodesign Institute is a research institute (not a product company) organized into 16 research centers addressing health, sustainability, and security challenges. Key offerings include: (1) Research services across multiple specialized centers including the Virginia G. Piper Center for Personalized Diagnostics, ASU-Banner Neurodegenerative Disease Research Center, and Center for Immunotherapy, Vaccines and Virotherapy; (2) Clinical Testing Laboratory providing COVID-19 saliva testing services; (3) Advanced research facilities including the Compact X-ray Free Electron Laser (CXFEL) for molecular imaging and the DNASU Plasmid Repository for research resources. The institute functions as an interdisciplinary research hub rather than a traditional product company.

Differentiator

Problem solved

Functional benefit

Products and services

• ASU Clinical Testing Laboratory State-certified clinical testing laboratory operated by ASU Biodesign Institute offering COVID-19 saliva PCR diagnostic testing with high throughput, rapid turnaround, and free public access during the COVID-19 pandemic.
• COVID-19 Saliva Testing Saliva-based COVID-19 PCR diagnostic test developed by Biodesign Institute, providing early detection via a non-invasive sample collection. Offered to the general public in the southwestern U.S. with rapid turnaround.
• Compact X-ray Free Electron Laser (CXFEL) First-of-its-kind compact particle accelerator producing ultrashort X-rays for studying protein structures in motion, cellular structures, and biomolecular dynamics. Supports research in photosynthesis, cancer development, infectious diseases, and biosensor development.

Quantifiable outcome

• $1 billion cumulative external funding attracted since formation
• +6 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Mayo Clinic ArizonacoreStrategic or Co-development PartnerCollaboration with Mayo Clinic in Arizona to eradicate cancer by developing therapeutic and preventative vaccines against cancer, including breast cancer vaccine development and gut microbiome research for obesity treatment.
• Banner HealthcoreStrategic or Co-development PartnerASU-Banner Neurodegenerative Disease Research Center partnership focused on Lou Gehrig's disease (ALS), Parkinson's disease, and other neurodegenerative diseases. Together with TGen and Mt. Sinai Health System, developing genetic sequencing database for 100 neurodegenerative diseases.
• Translational Genomics Research Institute (TGen)coreStrategic or Co-development PartnerCollaboration on neurodegenerative disease research and founding member of Arizona COVID-19 Genomics Union for tracking viral variants using next-generation sequencing and big data analysis.
• Arizona COVID-19 Genomics UnioncoreStrategic or Co-development PartnerPartnership with TGen and Arizona's public universities to use big data analysis and genetic mapping to inform healthcare providers and public policymakers during the COVID-19 pandemic.
• U.S. Army Medical Research Institute of Infectious DiseasescoreStrategic or Co-development PartnerCollaboration on infectious disease research including understanding human body's immune response, virus evasion mechanisms, and vaccine and therapy development.
• Skysong InnovationscoreImplementation/ SI/ Consulting PartnerASU's technology transfer and commercialization entity that proactively discovers matches between research output and important products and services, connecting commercialization experts with researchers to identify technology platforms with commercial promise.
• Cornell UniversityminorStrategic or Co-development PartnerCollaboration with Cornell food scientists to test if grape pomace (wine byproduct) could act as replacement for antibiotics in chicken feed.
• Mt. Sinai Health SystemcoreStrategic or Co-development PartnerPartner in developing genetic sequencing database for 100 neurodegenerative diseases alongside ASU-Banner and TGen.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Cold Spring Harbor Laboratory: Independent research and educational institution with overlapping cancer biology, neuroscience, and genomics programs. Comparable mix of fundamental research, training, and industry partnerships.
• Whitehead Institute: MIT-affiliated biomedical research institute with similar size, faculty depth, and focus on genomics, developmental biology, and disease research. Comparable structure as a university-embedded research institute.
• Broad Institute of MIT and Harvard: University-affiliated biomedical and genomic research institute operating in a similar model—mixing fundamental discovery, translational programs, large-scale facilities, and significant spinout activity. Direct functional peer in interdisciplinary biomedical research with similar funding scale and impact ambition.
• Wyss Institute for Biologically Inspired Engineering at Harvard: Harvard's biologically-inspired engineering institute explicitly mirrors Biodesign's nature-inspired interdisciplinary premise. Similar technology-translation model with industry partnerships and commercialization focus on diagnostics and bioinspired materials.
• Gladstone Institutes: UCSF-affiliated biomedical research institute focused on disease-oriented discovery with strong overlap in neurodegenerative, virology, and cardiovascular programs. Comparable scale, NIH funding reliance, and academic affiliation.
• Salk Institute for Biological Studies: Independent, nonprofit biological research institute with comparable faculty quality, Nobel-laureate history, and biology-plus-engineering interdisciplinary culture. Functions as a direct peer in fundamental biology research reputation and grant-winning scale.
• Scripps Research: Nonprofit biomedical research organization with closely overlapping programs in immunology, infectious disease, and chemistry-driven therapeutics. Comparable faculty caliber, NIH grant base, and translational pipelines.
• La Jolla Institute for Immunology: Nonprofit research organization focused on immunology and infectious disease—directly overlapping with Biodesign's immunotherapy, vaccines, and virotherapy center. Similar scale, NIH dependency, and academic affiliation model.

Broad incumbents

• Howard Hughes Medical Institute: Largest US private biomedical research organization supporting Investigators at universities, dwarfing Biodesign in scale and resources. Overlaps on biomedical discovery, talent investment, and translational pipeline but operates an Investigator-model rather than embedded institute.
• Allen Institute: Philanthropically funded research organization running large-scale programs in brain science, cell science, and immunology. Shares Biodesign's big-team, technology-rich approach and large grant-funded research scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCbRXwlofEQqGmNKnGUUg5XA
• Facebookfacebook.com/ASUBiodesign
• LinkedInlinkedin.com/company/asu-biodesign-institute
• Instagraminstagram.com/asubiodesign
• Xx.com/ASUBiodesign

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ASU Biodesign Institute